Marshall Wace
NTUS

Marshall Wace’s Natus Medical Inc NTUS Stock Holding History

Marshall Wace’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-166,756
Closed -$5.46M – 4062
2022
Q2 		$5.46M Buy
+166,756
New +$5.27M 0.01% 1272
2020
Q3 		– Sell
-100,240
Closed -$2.19M – 2035
2020
Q2 		$2.19M Buy
100,240
+62,840
+168% +$1.44M 0.02% 758
2020
Q1 		$865K Buy
+37,400
New +$1.09M 0.01% 836
2019
Q4 		– Sell
-35,839
Closed -$1.14M – 2195
2019
Q3 		$1.14M Buy
+35,839
New +$1.04M 0.01% 918
2019
Q2 		– Sell
-90,440
Closed -$2.29M – 1998
2019
Q1 		$2.29M Buy
+90,440
New +$2.7M 0.02% 701
2017
Q1 		– Sell
-8,986
Closed -$313K – 841
2016
Q4 		$313K Buy
+8,986
New +$353K ﹤0.01% 883
2016
Q2 		– Sell
-18,071
Closed -$694K – 1230
2016
Q1 		$694K Buy
+18,071
New +$673K 0.01% 787

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Marshall Wace's NTUS Position: Q3 2022 in Review

Marshall Wace sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 166,756 shares — an estimated $5.46M sold.

Marshall Wace first reported a position in NTUS in Q1 2016 and held it in 7 quarters. The position peaked at $5.46M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Marshall Wace reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 166,756 Natus Medical Inc shares in Q3 2022, an estimated $5.46M.
  • Marshall Wace first reported a position in Natus Medical Inc in Q1 2016 and held it in 7 quarters.
  • Marshall Wace's Natus Medical Inc position peaked at $5.46M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.